Results 1 to 10 of about 26,569 (289)

A Pilot Study of Differences in Antibody Responses of Intradermal and Intramuscular Injections of Botulinum Toxin Type A [PDF]

Dermatology and Therapy
Introduction Botulinum toxin type A (BoNT/A) is commonly used for both medical and aesthetic purposes. However, approximately 3% of long-term recipients develop resistance, potentially due to antibody formation.
Yuttana Srinoulprasert, Surachet Sirisuthivoranunt, Chattip Sripatumtong, Tunsuda Tansit, Chadakan Yan, Chalermkwan Apinuntham, Thanya Techapichetvanich, Sasima Eimpunth, Woraphong Manuskiatti, Rungsima Wanitphakdeedecha   +9 more
doaj   +2 more sources

Key refinements to a large animal model for measurement of real-time lymphatic transport [PDF]

BMC Medical Imaging
Background The inability to directly measure real-time lymphatic transport hinders our understanding of lymphatic disorders and effective monitoring of therapeutic interventions.
James E. Fanning, Valeria Bustos, Paul Jang, Jinhui Ser, Erin Kim, Jacquelyn Kinney, Atsushi Yamashita, Hak Soo Choi, Dhruv Singhal   +8 more
doaj   +2 more sources

Establishment of an Intradermal Canine IL-31-Induced Pruritus Model to Evaluate Therapeutic Candidates in Atopic Dermatitis

Veterinary Sciences, 2023
Pruritic models in healthy dogs utilizing intravenous administration of interleukin 31 (IL-31) bypass the “natural” itch sensation in AD, which is initiated by pruriceptive primary afferent neurons in the skin.
Jason Pearson, Renato Leon, Haley Starr, Sujung Jun Kim, Jonathan E. Fogle, Frane Banovic   +5 more
doaj   +1 more source

Two Non-gadolinium–based, Innovative Approaches to Preoperative Lymphangiography

Plastic and Reconstructive Surgery, Global Open, 2020
Summary:. Most magnetic resonance lymphangiography techniques employ intravenous gadolinium-based contrast agents, which carry a US Food and Drug Administration warning about gadolinium retention in the body when used intravenously.
Christine U. Lee, MD, PhD, James F. Glockner, MD, PhD, Gina K. Hesley, MD, Nathan J. Brinkman, PharmD, RPh, Nho V. Tran, MD   +4 more
doaj   +1 more source

Evaluation of the Safety and Immunogenicity of Fractional Intradermal COVID-19 Vaccines as a Booster: A Pilot Study

Vaccines, 2022
Intradermal vaccination using fractional dosages of the standard vaccine dose is one strategy to improve access to COVID-19 immunization. We conducted a pilot study in healthy adults in Thailand to evaluate the safety and immunogenicity of intradermal ...
Suvimol Niyomnaitham, Somruedee Chatsiricharoenkul, Zheng Quan Toh, Sansnee Senawong, Chatkamol Pheerapanyawaranun, Supaporn Phumiamorn, Paul V. Licciardi, Kulkanya Chokephaibulkit   +7 more
doaj   +1 more source

Contrast-enhanced ultrasound: a new tool for imaging the superficial lymphatic vessels of the upper limb

European Radiology Experimental, 2022
Background Despite the new lymphatic imaging methods, there is still a need for a straightforward method of detecting lymphatic abnormalities. Our goal was to investigate the feasibility of applying a contrast enhanced ultrasound (CEUS) procedure as a ...
Olli Lahtinen, Ritva Vanninen, Suvi Rautiainen   +2 more
doaj   +1 more source

Intramuscular versus intradermal botulinum toxin for forehead wrinkles: a review of side effects and efficacy

Dermatology Reports, 2023
Botulinum toxin type A (BTA) is a neurotoxin used for both cosmetic and non-cosmetic purposes. BTA is commonly administered as an intramuscular injection to treat wrinkles.
Mohammed Almashali, Rahaf Almutairi, Asem Shadid   +2 more
doaj   +1 more source

The Effects of Botulinum Toxin (BTXA) Dermal Injections on Facial Wrinkle Lines. [PDF]

Archives of Aesthetic Plastic Surgery, 2013
Facial rejuvenation using Botulinum toxin A is one of the most popular aesthetic procedures. Many cosmetic applications of Botulinum toxin A are under evaluation.
Sung Chul Park, Syeo Young Wee, Eun Soo Park, Bong Il Rho   +3 more
doaj   +1 more source

Intradermal ChAdOx1 Vaccine Following Two CoronaVac Shots: A Case Report

Vaccines, 2021
Inactivated SARS-CoV-2 vaccines are used in many countries with uncertain immunogenicity. Intradermal ChAdOx1 has been proposed as a resource-efficient heterologous third booster shot.
Ekachai Singhatiraj, Krit Pongpirul, Anan Jongkaewwattana, Nattiya Hirankarn   +3 more
doaj   +1 more source

Efficacy of intradermal allogeneic fibroblast injections in junctional epidermolysis bullosa

Russian Open Medical Journal, 2022
Objective — to assess the efficacy and safety of intradermal injections of allogeneic fibroblasts into non-healing wounds in a patient with junctional epidermolysis bullosa.
Alexey A. Kubanov, Arfenya E. Karamova, Vadim V. Chikin, Ekaterina S. Monchakovskaya, Mariya A. Nefedova   +4 more
doaj   +1 more source